Scientists have applied a technique called optical pooled CRISPR screening to identify potential new targets for Ebola drugs. This approach is part of a broader trend of using CRISPR screening for various medical applications, including cancer and infectious diseases. The use of CRISPR screening is being explored in multiple areas, with some studies focusing on its potential to enhance immunotherapies or understand genetic interactions in different diseases.